Bringing Research and Inventions to Life at University of Maryland, Baltimore

These researchers not traditional entrepreneurs and relied on the resources and support of the University of Maryland, Baltimore and University of Maryland Ventures to sell their invention to treat ARDS, or acute respiratory distress syndrome.UMB's Entrepreneurs of the Year are Jeffrey Hasday, MD, Univeristy of Maryland School of Medicine's Dr. Herbert Berger Professor of Medicine and Division Head, Pulmonary and Critical Care Medicine and Paul Shapiro, PhD, University of Maryland School of Pharmacy Professor, Department of Pharmaceutical Sciences Associate Dean of Research and Advanced Graduate Studies.Working to develop compounds to target inflammatory processes — with funding from UM Ventures, which is UMB’s tech transfer arm, and the UMB Institute for Clinical and Translational Research (ICTR) — Hasday, Shapiro, and their research team discovered a novel class of drugs that selectively inhibits the function of p38 MAPK that promotes disease-causing inflammation but preserves its beneficial functions.#ARDS #VentureCapital #MedSchool #BaltimoreTech #Baltimore #BioTech